Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Boston Scientific launches DirectSense technology

By

Boston Scientific DirectSense
Boston Sci’s DirectSense technology provides data on the impedance around the catheter tip to measure the ability of the tissue to respond to radiofrequency energy before physicians deliver therapy. [Image courtesy of Boston Scientific]
Boston Scientific (NYSE:BSX) announced today that it launched its DirectSense for monitoring the effect of radiofrequency (RF) energy during cardiac ablation procedures.

Marlborough, Mass.-based Boston Scientific’s DirectSense is available on the Rhythmia HDx mapping system that won FDA approval in April. Rhythmia HDx monitors changes in local impedance — electrical resistance — around the tip of the IntellaNav MiFi open-irrigated ablation catheter.

Get the full story on our sister site MassDevice. 

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.